China News Service, March 17th. According to Korean media reports, the South Korean new crown vaccination promotion team stated on the 17th that there is no evidence that there is a causal link between the AstraZeneca new crown vaccine and the occurrence of blood clots. Therefore, South Korea will continue as planned. Promote the vaccination work.
Data map: On March 4, local time, the staff in Incheon Airport, South Korea, wore protective clothing.
Photo by China News Agency reporter Zeng Nai
Some European countries have recently reported cases of adverse reactions such as thrombosis after vaccination with AstraZeneca.
At present, more than 20 countries around the world have suspended AstraZeneca vaccination.
The promotion team stated that about 570,000 people in South Korea have been vaccinated with the vaccine, and the relationship between the vaccination and thrombosis has not been confirmed.
Moreover, the AstraZeneca vaccine vaccinated in Korea is different from the vaccine used in Europe.
The promotion team also stated that it will continue to pay attention to whether there are abnormal reactions after vaccination with AstraZeneca, and will conduct further research with experts on the findings of the European Medicines Agency and cases in other countries.
The World Health Organization said on the 14th that it had found no evidence of thrombosis caused by the AstraZeneca vaccine and recommended not to stop the vaccination.
The European Medicines Agency stated that there is no indication that the AstraZeneca vaccine is the cause of blood clots in some vaccinators, and it "confirms" that the benefits of the AstraZeneca vaccine outweigh the risks.
However, the evaluation is in progress, and the relevant review results are expected to be announced on the 18th.